Raymond James & Associates Abbott Laboratories Call Options Transaction History

Raymond James & Associates

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2018 May 14, 2018	BUY	$56.27 - $63.62 $135,048 - $152,688	2,400 Added 8.54%	30,500 $20,000
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $1.84 Million - $1.97 Million	-34,200 Reduced 54.9%	28,100 $15,000
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $163,404 - $182,376	3,400 Added 5.77%	62,300 $103,000
Q2 2017 Aug 14, 2017	BUY	N/A	58,900	58,900 $236,000

3,224

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $224B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.